-
公开(公告)号:US08236795B2
公开(公告)日:2012-08-07
申请号:US12731056
申请日:2010-03-24
申请人: Lijun Sun , Elena Kostik , Teresa Przewloka , Howard P. Ng , Dinesh Chimmanamada , Zachary Demko
发明人: Lijun Sun , Elena Kostik , Teresa Przewloka , Howard P. Ng , Dinesh Chimmanamada , Zachary Demko
IPC分类号: A61K31/5377
CPC分类号: C07D403/12 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: The invention relates to heterocyclic compounds, compositions including the compounds and methods of using and methods of making thereof. The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.
摘要翻译: 本发明涉及杂环化合物,包括该化合物的组合物及其使用方法及其制备方法。 化合物(和组合物)尤其用于调节由IL-12介导的IL-12产生和过程。
-
公开(公告)号:US20120122869A1
公开(公告)日:2012-05-17
申请号:US13350296
申请日:2012-01-13
申请人: Weiwen Ying , David James , Shijie Zhang , Junghyun Chae , Teresa Przewloka , Howard P. Ng , Hao Li , Zachary Demko , Dinesh U. Chimmanamada , Chi-wan Lee , Zhenjian Du , Kevin Foley , Minghu Song , Lijun Sun , Keizo Koya , Dan Zhou , Shuzhen Qin
发明人: Weiwen Ying , David James , Shijie Zhang , Junghyun Chae , Teresa Przewloka , Howard P. Ng , Hao Li , Zachary Demko , Dinesh U. Chimmanamada , Chi-wan Lee , Zhenjian Du , Kevin Foley , Minghu Song , Lijun Sun , Keizo Koya , Dan Zhou , Shuzhen Qin
IPC分类号: A61K31/5377 , A61K31/4196 , A61P35/00 , C07D403/00 , A61K31/4709 , C07D249/12 , C07D413/10
CPC分类号: C07D417/04 , C07D249/12 , C07D401/04 , C07D403/04 , C07D403/10 , C07D403/14 , C07D405/04 , C07D405/10 , C07D405/14 , C07D409/04
摘要: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
摘要翻译: 本发明涉及取代的三唑化合物和包含取代的三唑化合物的组合物。 本发明还涉及在有需要的受试者中抑制Hsp90的活性的方法和在有需要的受试者中预防或治疗过度增殖性疾病如癌症的方法,其包括向受试者施用本发明的取代的三唑化合物, 或包含这种化合物的组合物。
-
公开(公告)号:US08053456B2
公开(公告)日:2011-11-08
申请号:US11807327
申请日:2007-05-25
申请人: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Przewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
发明人: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Przewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
IPC分类号: A61K31/4196 , C07D249/12
CPC分类号: C07D403/04 , A61K31/4196 , A61K31/422 , A61K31/4439 , A61K31/475 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D249/12 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/04 , C07D405/14 , C07D413/14 , C07D487/04
摘要: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
摘要翻译: 本发明涉及取代的三唑化合物和包含取代的三唑化合物的组合物。 本发明还涉及在有需要的受试者中抑制Hsp90的活性的方法和在有需要的受试者中预防或治疗过度增殖性疾病如癌症的方法,其包括向受试者施用本发明的取代的三唑化合物, 或包含这种化合物的组合物。
-
公开(公告)号:US20110105749A1
公开(公告)日:2011-05-05
申请号:US12815322
申请日:2010-06-14
申请人: Weiwen YING , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
发明人: Weiwen YING , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
IPC分类号: C07D403/10 , C07D417/10 , C07D413/10 , C07D405/10 , C07D401/10 , C07D249/14 , C07D249/12 , C07D473/34 , C07D413/12 , C07F9/6518
CPC分类号: C07D249/08 , A61K31/4196 , C07D249/12 , C07D401/04 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D473/00 , C07D473/34
摘要: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
-
公开(公告)号:US20110009397A1
公开(公告)日:2011-01-13
申请号:US12604970
申请日:2009-10-23
申请人: Weiwen Ying , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
发明人: Weiwen Ying , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
IPC分类号: A61K31/4196 , A61K31/4709 , A61K31/4439 , A61K31/4725 , A61K31/5377 , A61K31/538 , C12N5/00
CPC分类号: C07D249/08 , A61K31/4196 , C07D249/12 , C07D401/04 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D473/00 , C07D473/34
摘要: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
摘要翻译: 本发明涉及取代的三唑化合物和包含取代的三唑化合物的组合物。 本发明还涉及在有需要的受试者中抑制Hsp90的活性的方法和在有需要的受试者中预防或治疗过度增殖性疾病如癌症的方法,其包括向受试者施用本发明的取代的三唑化合物, 或包含这种化合物的组合物。
-
公开(公告)号:US07863270B2
公开(公告)日:2011-01-04
申请号:US11433603
申请日:2006-05-12
申请人: Zachary Demko , Lijun Sun , Howard P. Ng
发明人: Zachary Demko , Lijun Sun , Howard P. Ng
IPC分类号: A61K31/5377
CPC分类号: C07D239/42 , C07D239/48 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: The invention relates to cyclic hydrazone compounds and compositions including the cyclic hydrazone compounds according to formula (I): The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.
摘要翻译: 本发明涉及环腙化合物和包含根据式(I)的环腙化合物的组合物:化合物(和组合物)尤其用于调节IL-12产生和由IL-12介导的过程。
-
公开(公告)号:US07687498B2
公开(公告)日:2010-03-30
申请号:US12041662
申请日:2008-03-03
申请人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
发明人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
IPC分类号: A61K31/5377
CPC分类号: C07D413/12 , C04B35/632 , C07D213/77 , C07D401/12 , C07D405/12
摘要: This invention features compounds of formula (I): pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12-related diseases and disorders.
摘要翻译: 本发明的特征在于式(I)化合物:化合物的药物组合物,以及使用该化合物治疗特别是IL-12相关疾病和病症的方法。
-
公开(公告)号:US20080176840A1
公开(公告)日:2008-07-24
申请号:US11807327
申请日:2007-05-25
申请人: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Przewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
发明人: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Przewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
IPC分类号: A61K31/4196 , C07D401/14 , A61K31/4439 , C07D471/04 , A61K31/538 , A61K31/496 , A61P37/00 , A61P29/00 , A61P31/00 , A61P35/00 , A61K31/5377 , C07D413/14 , A61K31/52 , A61K31/4709 , C07D403/02
CPC分类号: C07D403/04 , A61K31/4196 , A61K31/422 , A61K31/4439 , A61K31/475 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D249/12 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/04 , C07D405/14 , C07D413/14 , C07D487/04
摘要: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
摘要翻译: 本发明涉及取代的三唑化合物和包含取代的三唑化合物的组合物。 本发明还涉及在有需要的受试者中抑制Hsp90的活性的方法和在有需要的受试者中预防或治疗过度增殖性疾病如癌症的方法,其包括向受试者施用本发明的取代的三唑化合物, 或包含这种化合物的组合物。
-
公开(公告)号:US20080167300A1
公开(公告)日:2008-07-10
申请号:US12041662
申请日:2008-03-03
申请人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
发明人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
IPC分类号: A61K31/5377 , A61P43/00
CPC分类号: C07D413/12 , C04B35/632 , C07D213/77 , C07D401/12 , C07D405/12
摘要: This invention features compounds of formula (I): pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12-related diseases and disorders.
摘要翻译: 本发明的特征在于式(I)化合物:化合物的药物组合物,以及使用该化合物治疗特别是IL-12相关疾病和病症的方法。
-
公开(公告)号:US07338951B2
公开(公告)日:2008-03-04
申请号:US10985696
申请日:2004-11-10
申请人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
发明人: Mitsunori Ono , Lijun Sun , Yumiko Wada , Teresa Przewloka , Hao Li , Howard P. Ng , Zachary Demko
IPC分类号: C07D413/04 , A61K31/5377
CPC分类号: C07D413/12 , C04B35/632 , C07D213/77 , C07D401/12 , C07D405/12
摘要: This invention features compounds of formula (I): pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12-related diseases and disorders.
摘要翻译: 本发明的特征在于式(I)化合物:化合物的药物组合物,以及使用该化合物治疗特别是IL-12相关疾病和病症的方法。
-
-
-
-
-
-
-
-
-